Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Hardcover, 2012 ed.)

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.

General

Imprint:	Springer-Verlag
Country of origin:	Germany
Series:	Recent Results in Cancer Research, 195
Release date:	April 2012
First published:	2012
Editors:	Michail Ignatiadis • Christos Sotiriou • Klaus Pantel
Dimensions:	235 x 155 x 20mm (L x W x T)
Format:	Hardcover
Pages:	254
Edition:	2012 ed.
ISBN-13:	978-3-642-28159-4
Categories:	Books > Medicine > Surgery > Surgical oncology Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General Promotions
LSN:	3-642-28159-1
Barcode:	9783642281594

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!